The Greenrose Holding Company Inc.
The Greenrose Holding Company Inc. (GNRS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
gnrs · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
The Greenrose Holding Company Inc.You GNRS | $0M | 0.00x | — | $1.12 |
 Beleave Inc. BLEVF | $0M | N/A | — | -$0.08 |
 EPIRUS Biopharmaceuticals, Inc. EPRSQ | $0M | N/A | — | — |
 Global WholeHealth Partners Corporation GWHP | $0M | N/A | — | -$0.05 |
 Integrated Pharmaceuticals, Inc. INTP | $0M | N/A | — | — |
 MEDirect Latino, Inc. MLTO | $0M | N/A | — | — |
 Orchid Ventures, Inc. ORVRF | $0M | N/A | — | -$0.06 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for The Greenrose Holding Company Inc. (GNRS) measures how much investors pay for each dollar of the company's trailing earnings. GNRS's current PE ratio of 0.00x is calculated by dividing its stock price of $0.00 by its TTM earnings per share of $1.12.
Frequently asked questions
GNRS pe ratio · 6 questionsGNRS's current PE ratio is 0.00x as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of $1.12. Data sourced from Financial Modeling Prep via GNRS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · The Greenrose Holding Company Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09